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Table 1 Empiric antimicrobial therapy based on the predicted meningeal pathogen 
Predisposing condition Bacterial pathogen Antibiotic 
Children and adults – 
community acquired 
Streptococcus pneumoniae 
and Neisseria meningitidis 
Third or fourth generation 
cephalosporin plus 
vancomycin 
Otitis, mastoiditis, sinusitis Streptococci spp., gram-
negative anaerobes 
(Bacteroides sp., 
Fusobacterium sp.), S. aureus, 
Haemophilus sp., 
Enterobacteriaceae 
Third or fourth generation 
cephalosporin plus 
vancomycin plus  
metronidazole
Adults over the age of 55 
and those with chronic illness 
Streptococcus pneumoniae, 
gram-negative bacilli, 
Neisseria meningitidis, Listeria 
monocytogenes, Haemophilus 
influenzae 
Third or fourth generation 
cephalosporin plus 
vancomycin plus ampiciilin 
Endocarditis viridans streptococci, S. 
aureus, Streptococcus bovis, 
HACEK group, Enterococci 
Third or fourth generation 
cephalosporin plus 
vancomycin 
Immunosuppressed Streptococcus pneumoniae, 
Listeria monocytogenes, 
Haemophilus influenzae 
Third or fourth generation 
cephalosporin plus 
vancomycin plus ampicillin 
Postneurosurgical Staphylococci, gram-negative 
bacilli 
Vancomycin plus meropenem 
or vancomycin plus 
ceftazidime 
Intraventricular device Staphylococci, gram-negative 
bacilli, anaerobes 
Vancomycin plus meropenem  
or vancomycin plus 
ceftazidime plus 
metronidazole 
The HACEK group is Haemophilus sp., Actinobacillus actinomycetemcomitans, Cardiobacterium hominis, 
Eikenella corrodens,and Kingella kingae.  
Table 2. Recommended doses for the antibiotics commonly used in the treatment of bacterial 
central nervous system infections 
Antibiotic agent Total daily dosage (dosing interval in 
hours) 
Ampicillin Infants and children: 300 mg/kg/d (q6h) 
Adult: 12 g/d (q4-6h) 
Cefepime Infants and children: 150 mg/kg/d (q8h) 
Adult: 6 g/d (q8h) 
Cefotaxime Infants and children: 225-300 mg/kg/d (q6-8h) 
Adult: 8-12 g/d (q4-6h) 
Ceftriaxone Infants and children: 80-100 mg/kg/d (q12h) 
Adult: 4 g/d (q12h) 
Gentamicin Infants and children: 7.5 mg/kg/d (q8h) 
Adult: 5 mg/kg/d (q8h) 
Meropenem Infants and children: 120 mg/kg/d (q8h) 
Adult: 6 g/d (q8h) 
Metronidazole Infants and children: 30 mg/kg/d (q6h)  
Adult dose: 2000 mg/day (q6h) 
Nafcillin Infants and children: 200 mg/kg/d (q6h) 
Adult: 9-12 g/d (q4h) 
Penicillin G Infants and children: 0.3 mU/kg/d (q4-6h) 
Adult: 24 million units/d (q4-6h) 
Rifampin  Infants and children: 10-20 mg/kg/d (q12-24h) 
Adults: 600-1200 mg/d (q12h) 
 
Vancomycin* Infants and children: 60 mg/kg/d (q6h) 
Adults: 45-60 mg/kg/d (q6-12h) 
Chemoprophylaxis 
Neisseria meningitidis 
Rifampin 600 mg twice daily for two days or 
Ceftriaxone 250 mg intramuscular or 














































































Table 3 Cerebrospinal fluid diagnostic studies for meningitis 
Cell count with differential 
Glucose and protein concentration 
 
Stain and culture 
 Gram’s stain and bacterial culture 
 India ink and fungal culture 
 Viral culture 
 Acid fast smear and M. tuberculosis culture 
 
Antigens/Antibodies if fungal meningitis is in the differential 
 Cryptococcal polysaccharide antigen 
 Histoplasma polysaccharide antigen 
 C. immitis complement fixation antibody 
 
Polymerase chain reaction 
 Broad range bacterial PCR (16S ribosomal DNA) 
 Specific meningeal pathogen PCR 
 Reverse transcriptase PCR for enteroviruses 
 PCR for herpes simplex virus type 1 and 2 
 PCR for West Nile virus 
 PCR for Epstein Barr virus 
 PCR for varicella zoster virus 
 PCR for M. tuberculosis 
 PCR for HIV RNA 
 
Antibodies 
 Herpes simplex virus (serum and CSF IgG to calculate antibody ratio) 
 Varicella zoster virus IgM, and IgG antibody index 
 Arthropod-borne viruses (West Nile virus IgM) 
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